Pharma Forum Dialogues

New York Pharma Forum’s Top 3 Most-Read Blog Posts of 2014

Posted by New York Pharma Forum Inc. on Mar 24, 2015 7:16:00 PM


Pharma industry leaders share their expertise on Pharma Forum Dialogues, the blog launched by New York Pharma Forum in 2014.  Here are the top 3 most-read blog posts of 2014.


Inter Partes Review Adds Another Twist to Hatch Waxman Litigation

Inter Partes Review is another way besides Hatch Waxman litigation to challenge a patent's validity. 


By: David M. Conca, Partner, Ligitation Department and 
      Nao Takada, Associate, Litigation Department,
      Paul Hastings LLP

Ethnic bridging studies are used to measure the impact of ethnic differences on the absorption, distribution, metabolism, or excretion of drugs.

By: Gary K. Zammit, Ph. D., 
President & CEO, Clinilabs

Pain Drug Development to Address High Unmet Needs

Pain drug development is a growing market with high unmet needs. Pharma companies are working on overcoming safety hurdles.

By: Amit Dhawan, MD, and Michael Fronstin,
Kantar Health


How to Submit a  Pharma Forum Dialogues Blog Post

Follow Us

Subscribe to Email Updates

Learn about Joining the New York Pharma Forum

Recent Posts